JAAQ raises €15 million to expand digital health platform
London-based startup JAAQ, a clinically governed digital health and engagement platform, has secured a €15 million (£13 million) Series A funding round. The investment will support the company’s mission to deliver scalable, evidence-led support for mental and behavioral health through an interactive, video-led platform.
A clinically governed approach to digital mental health
JAAQ positions itself at the intersection of digital health, mental health, and patient engagement. The platform is designed to give users structured, clinically validated answers to sensitive questions around anxiety, depression, trauma, and other conditions, using interactive video content developed in collaboration with clinicians and subject-matter experts.
The company operates under strict clinical governance frameworks, ensuring that information is accurate, up to date, and aligned with best-practice guidelines. This approach aims to differentiate JAAQ from generic wellness apps by focusing on medical credibility, safety, and measurable outcomes for both individuals and enterprise clients.
Funding to fuel product development and global reach
The €15 million Series A will be used to scale the platform’s technology, deepen its content library, and expand commercial partnerships with employers, healthcare providers, and insurers. The fresh capital is also expected to accelerate the rollout of new features powered by AI algorithms and data-driven personalization, while maintaining strict oversight from clinical experts.
Enterprise and healthcare partnerships in focus
JAAQ is increasingly targeting large organizations seeking to improve workforce wellbeing and reduce pressure on traditional health services. By offering a self-service, always-on support channel, the platform aims to complement existing mental health pathways and shorten the time it takes for people to access reliable information and early intervention.
With this Series A round, JAAQ is positioning itself as a key player in Europe’s rapidly growing digital therapeutics and healthtech market, as demand for scalable, clinically trusted mental health solutions continues to rise worldwide.